MedPath

Patient-specific 3D models to improve doctor-patient communicatio

Conditions
I67.10
I67.11
Registration Number
DRKS00027893
Lead Sponsor
niversitätsklinikum Leipzig
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
24
Inclusion Criteria

Neurovascular pathologies to be treated electively
- Written consent to study available
- Study participants >/= 18 years
- Indication for interventional or surgical treatment of the intracranial vascular change given by the treating physicians in neuroradiology or neurosurgery.

Exclusion Criteria

- Neurovascular pathologies requiring emergency care
- Written consent to study is missing
- Study participants < 18 years
- Contraindications for interventional or surgical treatment of the intracranial vascular change by the treating physicians in neuroradiology or neurosurgery.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the investigation of improved information transfer between doctor and patient through the patient-specific 3D models, especially with regard to understanding their own disease, the impact on lifestyle and the planned therapy.
Secondary Outcome Measures
NameTimeMethod
The costs and the time required for building and printing of the 3D models are to be recorded as secondary endpoints and a statement is to be made about the applicability in relation to the benefit in everyday clinical practice.
© Copyright 2025. All Rights Reserved by MedPath